PL2436672T3 - Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny - Google Patents

Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny

Info

Publication number
PL2436672T3
PL2436672T3 PL10780439T PL10780439T PL2436672T3 PL 2436672 T3 PL2436672 T3 PL 2436672T3 PL 10780439 T PL10780439 T PL 10780439T PL 10780439 T PL10780439 T PL 10780439T PL 2436672 T3 PL2436672 T3 PL 2436672T3
Authority
PL
Poland
Prior art keywords
shock agent
diaminotrifluoromethylpyridine derivative
diaminotrifluoromethylpyridine
derivative
shock
Prior art date
Application number
PL10780439T
Other languages
English (en)
Inventor
Shuichi Yotsuya
Hiroshi Shikama
Original Assignee
Ishihara Sangyo Kaisha, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha, Ltd. filed Critical Ishihara Sangyo Kaisha, Ltd.
Publication of PL2436672T3 publication Critical patent/PL2436672T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL10780439T 2009-05-28 2010-05-17 Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny PL2436672T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009129578 2009-05-28

Publications (1)

Publication Number Publication Date
PL2436672T3 true PL2436672T3 (pl) 2017-09-29

Family

ID=43222595

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10780439T PL2436672T3 (pl) 2009-05-28 2010-05-17 Środek przeciwwstrząsowy zawierający pochodną diaminotrifluorometylopirydyny

Country Status (9)

Country Link
US (1) US8604212B2 (pl)
EP (1) EP2436672B1 (pl)
JP (1) JP5584518B2 (pl)
CA (1) CA2761597C (pl)
ES (1) ES2629428T3 (pl)
HU (1) HUE033310T2 (pl)
PL (1) PL2436672T3 (pl)
PT (1) PT2436672T (pl)
WO (1) WO2010137484A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018361503A1 (en) * 2017-11-02 2020-05-14 Ishihara Sangyo Kaisha, Ltd. Sustained-release medical composition
EP3760200A4 (en) * 2018-03-01 2021-12-15 Ishihara Sangyo Kaisha, Ltd. PHARMACEUTICAL COMPOSITION WITH EXCELLENT STORAGE STABILITY
JP7553826B2 (ja) 2019-05-15 2024-09-19 石原産業株式会社 N-(2-エチルスルホニルアミノ-5-トリフルオロメチル-3-ピリジル)シクロヘキサンカルボキサミド・一ナトリウム塩の無水和物結晶体
US20230372315A1 (en) 2020-09-29 2023-11-23 Ishihara Sangyo Kaisha, Ltd. Liquid-State Pharmaceutical Composition Exhibiting Excellent Preservative Effectiveness

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260320A (en) 1990-07-10 1993-11-09 Ishihara Sangyo Kaisha Ltd. Diaminotrifluoromethylpyridine compounds and phospholipase A2 inhibitor containing them
JPH05170742A (ja) * 1991-05-24 1993-07-09 Ishihara Sangyo Kaisha Ltd ジアミノトリフルオロメチルピリジン誘導体、それらの製造方法及びそれらを含有するホスホリパーゼ▲a2▼阻害剤
DE69127595T2 (de) 1990-07-10 1998-01-22 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyrimidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Phospholipase-A2-Inhibitoren
ZA915023B (en) 1990-07-10 1992-05-27 Ishihara Sangyo Kaisha Diaminotrifluoromethylpyridine derivatives,process for their production and phospholipase a2 inhibitor containing them
JPH06135934A (ja) 1991-12-27 1994-05-17 Ishihara Sangyo Kaisha Ltd ピリジン誘導体又はその塩を含有するホスホリパーゼ▲a2▼阻害剤、抗炎症剤又は抗膵炎剤
JP3353301B2 (ja) * 1995-07-24 2002-12-03 藤沢薬品工業株式会社 Pla▲下2▼阻害剤としてのエステル類およびアミド類
TW415843B (en) 1997-02-28 2000-12-21 Ishihara Sangyo Kaisha Anti-cancer pharmaceutical compositions comprising a diaminotrifluoromethylpyridine derivatives or the pharmaceutically acceptable salts thereof
TWI283578B (en) 2000-01-31 2007-07-11 Ishihara Sangyo Kaisha Therapeutic agent for alimentary disease comprising diaminotrifluoromethylpyridine derivative
US6664279B2 (en) 2000-02-01 2003-12-16 Ishihara Sangyo Kaisha, Ltd. Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
JP4848092B2 (ja) * 2000-02-01 2011-12-28 石原産業株式会社 ジアミノトリフルオロメチルピリジン誘導体を含有する肺不全の治療剤又は予防剤
EP1303262A2 (en) * 2000-07-14 2003-04-23 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
US20040110825A1 (en) 2001-06-29 2004-06-10 Andrew Loh Method for treating sepsis
JP5170742B2 (ja) 2005-12-28 2013-03-27 積水メディカル株式会社 凝集測定用試薬及び凝集測定方法
JP2009129578A (ja) 2007-11-20 2009-06-11 K-One Create Corp 棚板用の照明構造

Also Published As

Publication number Publication date
EP2436672A1 (en) 2012-04-04
CA2761597A1 (en) 2010-12-02
JP5584518B2 (ja) 2014-09-03
HUE033310T2 (en) 2017-11-28
EP2436672B1 (en) 2017-04-12
US20120059039A1 (en) 2012-03-08
ES2629428T3 (es) 2017-08-09
WO2010137484A1 (ja) 2010-12-02
JP2011006384A (ja) 2011-01-13
EP2436672A4 (en) 2012-11-28
PT2436672T (pt) 2017-05-30
CA2761597C (en) 2016-12-20
US8604212B2 (en) 2013-12-10

Similar Documents

Publication Publication Date Title
EP2420493A4 (en) HALOALKYLSULFONANILIDE DERIVATIVES
PL2433940T3 (pl) Pochodna spiroimidazolonu
EP2412708A4 (en) SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE
EP2514747A4 (en) SUBSTITUTED AMINOTHIAZINE DERIVATIVE
ZA201203205B (en) Benzimidazole-imidazole derivatives
IL217956A0 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives
IL217953A0 (en) 5-fluoropyrimidinone derivatives
PL2397480T3 (pl) Pochodna diazepinodionu
EP2495238A4 (en) NEW 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE
IL216007A0 (en) Isoxazole-pyridine derivatives
IL220526A0 (en) Kokumi-imparting agent
IL215109A0 (en) Isoxazole-pyridazine derivatives
ZA201106855B (en) Oxasiazole derivatives
IL220527A0 (en) Kokumi-imparting agent
IL214941A0 (en) Isoxazole-pyrazole derivatives
IL217952A0 (en) N1-acyl-5-fluoropyrimidinone derivatives
ZA201104991B (en) Deoxyactagardine derivatives
ZA201202899B (en) 5-hydroxypyrimidine-4-carboxamide derivative
IL216761A0 (en) Pyrazinooxazepine derivatives
IL216524A0 (en) 17beta-alkyl-17alpha-oxy-estratrienes
ZA201104279B (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives